Related references
Note: Only part of the references are listed.Feasibility of a Breath Test for Monitoring Adherence to Vaginal Administration of Antiretroviral Microbicide Gels
Timothy E. Morey et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
Robert Belknap et al.
PLOS ONE (2013)
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
Craig W. Hendrix et al.
PLOS ONE (2013)
Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men
Nicolette A. Louissaint et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz
Wiete Kromdijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Female Genital Tract After Simulated Vaginal Intercourse
Nicolette A. Louissaint et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Preexposure Prophylaxis for HIV Infection among African Women
Lut Van Damme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comparison of Antiretroviral Adherence Questions
Karina M. Berg et al.
AIDS AND BEHAVIOR (2012)
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection
Peter L. Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-negative Men
Kevin C. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism
Michael Roche et al.
JOURNAL OF VIROLOGY (2011)
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
Salim S. Abdool Karim et al.
LANCET (2011)
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
Kristine B. Patterson et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots
Roland J. W. Meesters et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults
Jeffrey M. Jacobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
Lieven Baert et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Maraviroc Concentrates in the Cervicovaginal Fluid and Vaginal Tissue of HIV-Negative Women
Julie B. Dumond et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
Peter M. Edelbroek et al.
THERAPEUTIC DRUG MONITORING (2009)
Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
J. Gerardo Garcia-Lerma et al.
PLOS MEDICINE (2008)
Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled Trial
Frederick L. Altice et al.
CLINICAL INFECTIOUS DISEASES (2007)
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial
Frederick L. Altice et al.
CLINICAL INFECTIOUS DISEASES (2007)
Visual analog scale of ART adherence: Association with 3-day self-report and adherence barriers
K. Rivet Amico et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups
GM Lucas et al.
CLINICAL INFECTIOUS DISEASES (2006)
The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors - Implications for once-daily dosing
DJ Back et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens
T Hawkins et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry
T Koal et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting
JH Oyugi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy and safety of emtricitabine vs stavudine in combination therapy in anti retroviral-naive patients - A randomized trial
MS Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection
LH Wang et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Once-daily administration of antiretrovirals - Pharmacokinetics of emerging therapies
AM Taburet et al.
CLINICAL PHARMACOKINETICS (2003)
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials
S Mannheimer et al.
CLINICAL INFECTIOUS DISEASES (2002)
Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment
LR Kirkland et al.
CLINICAL INFECTIOUS DISEASES (2002)
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
JC Walsh et al.
AIDS (2002)
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
MA Chesney et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2000)
Share Paper
